Liangjun Yang

539 total citations
33 papers, 388 citations indexed

About

Liangjun Yang is a scholar working on Surgery, Pharmacology and Molecular Biology. According to data from OpenAlex, Liangjun Yang has authored 33 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Liangjun Yang's work include Pharmacological Effects of Natural Compounds (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Cancer-related molecular mechanisms research (4 papers). Liangjun Yang is often cited by papers focused on Pharmacological Effects of Natural Compounds (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Cancer-related molecular mechanisms research (4 papers). Liangjun Yang collaborates with scholars based in China and United States. Liangjun Yang's co-authors include Jiajie Zhu, Huafeng Pan, Shan Liu, Ji‐Cheng Li, Feng‐Yun Ma, Zhihua Zhang, Tingxian Tao, Maoyi Yang, Jiali Li and Yugui Tao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Surface Science and Medicine.

In The Last Decade

Liangjun Yang

29 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangjun Yang China 12 115 79 72 60 57 33 388
Qingling Jia China 14 201 1.7× 50 0.6× 39 0.5× 105 1.8× 40 0.7× 32 608
Zhilin Chen China 14 133 1.2× 103 1.3× 24 0.3× 28 0.5× 22 0.4× 31 545
Zhiqin Wu China 16 260 2.3× 84 1.1× 27 0.4× 94 1.6× 30 0.5× 37 774
Jiahuan Li China 13 150 1.3× 25 0.3× 35 0.5× 32 0.5× 34 0.6× 24 463
Xueying Peng China 13 119 1.0× 53 0.7× 34 0.5× 37 0.6× 19 0.3× 30 432
Minghua Xian China 15 245 2.1× 59 0.7× 154 2.1× 26 0.4× 112 2.0× 53 634
Junming Chen China 12 136 1.2× 50 0.6× 104 1.4× 46 0.8× 39 0.7× 32 412
Dongyin Wang China 11 97 0.8× 60 0.8× 57 0.8× 20 0.3× 26 0.5× 23 448
Fuyan Liu China 16 203 1.8× 35 0.4× 11 0.2× 31 0.5× 36 0.6× 35 541
Weimin Yang China 15 299 2.6× 44 0.6× 20 0.3× 24 0.4× 63 1.1× 65 723

Countries citing papers authored by Liangjun Yang

Since Specialization
Citations

This map shows the geographic impact of Liangjun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangjun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangjun Yang more than expected).

Fields of papers citing papers by Liangjun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangjun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangjun Yang. The network helps show where Liangjun Yang may publish in the future.

Co-authorship network of co-authors of Liangjun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangjun Yang. A scholar is included among the top collaborators of Liangjun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangjun Yang. Liangjun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Liangjun, et al.. (2025). The potential of Sijunzi decoction in the fight against gastrointestinal disorders: a review. Frontiers in Pharmacology. 16. 1464498–1464498. 1 indexed citations
2.
Zhu, Jiajie, Liangjun Yang, Fang Zheng, et al.. (2025). Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation. Molecular Medicine Reports. 32(6). 1–9.
3.
Zheng, Fang, et al.. (2024). A delayed gastric antral vascular ectasia: A case report and literature review. Medicine. 103(52). e40831–e40831. 1 indexed citations
4.
Li, Xinlong, et al.. (2024). Curcumin for gastric cancer: Mechanism prediction via network pharmacology, docking, and in vitro experiments. World Journal of Gastrointestinal Oncology. 16(8). 3635–3650. 2 indexed citations
5.
Li, Wanzhen, Yongqi Yang, Jun Wang, et al.. (2023). Establishment of bone-targeted nano-platform and the study of its combination with 2-deoxy-d-glucose enhanced photodynamic therapy to inhibit bone metastasis. Journal of the mechanical behavior of biomedical materials. 150. 106306–106306. 5 indexed citations
6.
Zhang, Weiwei, Liangjun Yang, Hanghang Li, et al.. (2023). Synthesis of 2D molybdenum disulfide nanoplatform with effective chemo-photothermal antifungal activities and extended shelf-life of fruits. Materials Chemistry and Physics. 296. 127350–127350.
7.
Zhu, Jiajie, et al.. (2023). Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression. Journal of Medical Microbiology. 72(5). 7 indexed citations
8.
Yang, Liangjun, Xinying Liu, Jiajie Zhu, et al.. (2023). Progress in traditional Chinese medicine against chronic gastritis: From chronic non-atrophic gastritis to gastric precancerous lesions. Heliyon. 9(6). e16764–e16764. 18 indexed citations
9.
Zheng, Jiayi, Wei He, Haoyu Zhong, et al.. (2021). Chronic stress accelerates the process of gastric precancerous lesions in rats. Journal of Cancer. 12(14). 4121–4133. 13 indexed citations
10.
Yang, Liangjun, et al.. (2020). Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach. BioMed Research International. 2020(1). 3860213–3860213. 27 indexed citations
11.
Yang, Liangjun, et al.. (2020). Effects of weifuchun tablet for chronic atrophic gastritis. Medicine. 99(22). e20374–e20374. 7 indexed citations
12.
Yang, Liangjun, et al.. (2020). Exploration in the Mechanism of Kaempferol for the Treatment of Gastric Cancer Based on Network Pharmacology. BioMed Research International. 2020(1). 5891016–5891016. 20 indexed citations
13.
Yang, Maoyi, et al.. (2020). Effects of rebamipide for chronic atrophic gastritis. Medicine. 99(25). e20620–e20620. 9 indexed citations
14.
Liu, Wei, Huafeng Pan, Liangjun Yang, et al.. (2020). Panax ginseng C.A. Meyer (Rg3) Ameliorates Gastric Precancerous Lesions in Atp4a−/− Mice via Inhibition of Glycolysis through PI3K/AKT/miRNA‐21 Pathway. Evidence-based Complementary and Alternative Medicine. 2020(1). 2672648–2672648. 29 indexed citations
15.
Yang, Maoyi, et al.. (2020). Corrigendum: The Efficacy and Safety of Qiming Granule for Dry Eye Disease: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 11. 597639–597639.
16.
Yang, Liangjun, et al.. (2020). A Systematic Review of the Mechanisms Underlying Treatment of Gastric Precancerous Lesions by Traditional Chinese Medicine. Evidence-based Complementary and Alternative Medicine. 2020(1). 9154738–9154738. 15 indexed citations
17.
Yang, Maoyi, Liangjun Yang, Chunguang Xie, et al.. (2020). Network Pharmacology‐Based Identification of the Mechanisms of Shen‐Qi Compound Formula in Treating Diabetes Mellitus. Evidence-based Complementary and Alternative Medicine. 2020(1). 5798764–5798764. 8 indexed citations
18.
Yang, Maoyi, et al.. (2019). The efficacy and safety of qiming granule in dry eye disease. Medicine. 98(39). e17121–e17121. 3 indexed citations
19.
Yang, Liangjun, et al.. (2018). A network pharmacology approach to investigate the mechanisms of Si-Jun-Zi decoction in the treatment of gastric precancerous lesions. SHILAP Revista de lepidopterología. 3(6). 273–285. 1 indexed citations
20.
Yang, Liangjun. (2008). On the discrimination method of flaw types in oil pipeline inspection. Journal of Hefei University of Technology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026